GetTopicDetailResponse(id=4ea2115448b0, topicName=維持性血液透析, introduction=, content=維持性血液透析 恩丹西酮, image=null, comments=0, allHits=526, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Jun 13 10:03:26 CST 2024, time=2024-06-13, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=116106, tagList=[TagDto(tagId=116106, tagName=維持性血液透析)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2209628, encodeId=cd71220962838, content=<a href='/topic/show?id=4ea2115448b0' target=_blank style='color:#2F92EE;'>#維持性血液透析#</a> <a href='/topic/show?id=711a11544939' target=_blank style='color:#2F92EE;'>#恩丹西酮#</a>, objectTitle=JASN：血透患者服用恩丹西酮是否會增加突發(fā)心臟死亡風險？, objectType=article, longId=829875, objectId=fe4c8298e5b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240613/1718243890595_92910.jpg, objectUrl=/article/show_article.do?id=fe4c8298e5b1, replyNumber=0, likeNumber=82, createdTime=2024-06-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe4c8298e5b1, moduleTitle=JASN：血透患者服用恩丹西酮是否會增加突發(fā)心臟死亡風險？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fe4c8298e5b1)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-06-13發(fā)表于上海
